Letter Regarding the Published Article "Population Pharmacokinetics and Dose Optimization of Valganciclovir and Ganciclovir in Lung Transplant Recipients". [PDF]
Sah SS, Kumbhalwar A.
europepmc +1 more source
Cytomegalovirus Breakthrough in Pediatric Cardiac Transplant Recipients Receiving Weight-Based Dosing Valganciclovir Prophylaxis. [PDF]
Poirier N +5 more
europepmc +1 more source
An Uncommon Case of Disseminated Human Herpesvirus 6 Infection in an Immunocompetent Adult. [PDF]
Caetano IL +4 more
europepmc +1 more source
Anasarca Secondary to Cytomegalovirus Viremia in a Post-Liver Transplant Patient. [PDF]
Albusta N.
europepmc +1 more source
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease. [PDF]
Ellis J +10 more
europepmc +1 more source
Diagnosis of EBV and HCMV infections in pediatric heart transplant recipients. [PDF]
Gabeleh F +3 more
europepmc +1 more source
Secondary Prophylaxis With Bioequivalent Generic Letermovir in Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report. [PDF]
Baheti A, Bharat S.
europepmc +1 more source
CMV Infection in Pediatric Liver Transplantation and Comparison of Prophylaxis Methods Depending on Donor Serostatus. [PDF]
Barut D +10 more
europepmc +1 more source
Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries. [PDF]
Prats JAGG +8 more
europepmc +1 more source
Does human cytomegalovirus provide a novel therapeutic target for patients with glioblastoma? [PDF]
Söderberg-Naucler C +3 more
europepmc +1 more source

